biotech · Advanced Solid Tumors · Tumor, Solid · EIKN
Eikon Therapeutics
Eikon Therapeutics trial registry — 16 ClinicalTrials.gov studies with program phase, status, and indication context.
230 Harriet Tubman Way, Millbrae, CA 94030, US HQ
2019 Founded
404 Employees
Public company Type
EIKN · NYSE Ticker
Company details
- Status
- Public
- HQ
- 230 Harriet Tubman Way, Millbrae, CA 94030, US
- Founded
- 2019
- Employees
- 404
- Programs
- 15
- Drugs
- 13
- Patents
- 4
Eikon Therapeutics clinical trials
Registry index of 16 ClinicalTrials.gov studies linked to Eikon Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Eikon Therapeutics trial registry — 16 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Eikon Therapeutics.
-
EIK1005-002 — Phase 2
Clinical update -
EIK1003-001 — Phase 2
Clinical update -
EIK1001-008 — Phase 2
Clinical update -
EIK1001-006 — Phase 3
Clinical update -
EIK1004 20mg Tablets, EIK1004 5mg Tablets — Phase 2
Clinical update -
EIK1001 — Phase 3
Clinical update -
EIK1001 — Phase 3
Clinical update -
Association atezolizumab + BDB001 + RT — Phase 2
Clinical update